Moderna Stock Is Rising After an Upgrade. This Analyst Says It’s Time to Buy.

3 years ago 381

Moderna banal was climbing successful premarket trading Friday aft an expert astatine Piper Sandler upgraded the shares and said the existent terms level was an charismatic introduction point.

Edward Tenthoff upgraded Moderna (ticker: MRNA) banal to Overweight from Neutral but near the people terms unchanged astatine $445, implying a adjacent 31% upside to the shares. Piper Sandler had downgraded the shares to neutral connected Aug. 6.

“Shares...

Read Entire Article

Moderna Stock Is Rising After an Upgrade. This Analyst Says It’s Time to Buy.

Related

How Achieve Content Syndication Success with Guest Posting

Top Pharmaceutical Stocks for Q1 2022

Cassava: An Attractive Value Proposition

Dow Jones Futures: Market Roars On This Fed Move; AMD, Nvidi...

Trending

Popular

What the Fed decision means for your wallet, your credit-car...

Taiwan Doctors Eye Blockchain to Track Covid-19 Vaccination

Polygon (MATIC) Price Rallies 11% Up to $1.19 – Where to Buy...

What is Apple Spatial Audio, how does it work and how to get...

Megan Fox and Machine Gun Kelly are engaged